CM Hospitalar S/A (BVMF:VVEO3)
Brazil · Delayed Price · Currency is BRL 1.450
-0.050 (-3.33%)
At close: Jan 30, 2026
CM Hospitalar S/A Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 11,371 | 11,583 | 11,084 | 8,747 | 6,219 | 4,413 | |
Revenue Growth (YoY) | -1.57% | 4.51% | 26.72% | 40.65% | 40.91% | 46.96% |
Cost of Revenue | 10,026 | 10,277 | 9,349 | 7,350 | 5,121 | 3,775 |
Gross Profit | 1,345 | 1,306 | 1,735 | 1,397 | 1,097 | 638.47 |
Selling, General & Admin | 1,461 | 1,473 | 1,146 | 863.53 | 671.86 | 420.34 |
Other Operating Expenses | 187.68 | 537.62 | -24.34 | 10.28 | -71.19 | 18.64 |
Operating Expenses | 1,669 | 2,121 | 1,113 | 879.77 | 602.01 | 441.2 |
Operating Income | -324.62 | -814.99 | 621.46 | 516.89 | 495.3 | 197.27 |
Interest Expense | -567.23 | -489.45 | -469.03 | - | -386.75 | -351.45 |
Interest & Investment Income | 83.01 | 91.12 | 103.08 | - | 303.31 | 344.01 |
Earnings From Equity Investments | -11.73 | -11.86 | -1.68 | -3.53 | -3 | -0.25 |
Currency Exchange Gain (Loss) | -3.16 | -54.93 | 17.39 | - | - | - |
Other Non Operating Income (Expenses) | -229.74 | -275.31 | -149.39 | -305.28 | - | - |
EBT Excluding Unusual Items | -1,053 | -1,555 | 121.83 | 208.08 | 408.85 | 189.59 |
Asset Writedown | -50.45 | -45.58 | - | - | - | - |
Legal Settlements | 9.44 | 9.44 | - | - | - | - |
Other Unusual Items | 116.06 | - | 16.67 | - | - | - |
Pretax Income | -962.61 | -1,592 | 138.5 | 208.08 | 408.85 | 189.59 |
Income Tax Expense | 33.89 | -176.06 | -221.42 | -51.65 | 13.7 | 67.82 |
Earnings From Continuing Operations | -996.5 | -1,415 | 359.92 | 259.73 | 395.16 | 121.77 |
Net Income | -996.5 | -1,415 | 359.92 | 259.73 | 395.16 | 121.77 |
Net Income to Common | -996.5 | -1,415 | 359.92 | 259.73 | 395.16 | 121.77 |
Net Income Growth | - | - | 38.57% | -34.27% | 224.52% | 240.63% |
Shares Outstanding (Basic) | 316 | 318 | 300 | 284 | 262 | 225 |
Shares Outstanding (Diluted) | 316 | 318 | 300 | 284 | 262 | 225 |
Shares Change (YoY) | -1.14% | 5.88% | 5.74% | 8.48% | 16.35% | 44.65% |
EPS (Basic) | -3.16 | -4.46 | 1.20 | 0.92 | 1.51 | 0.54 |
EPS (Diluted) | -3.16 | -4.46 | 1.20 | 0.92 | 1.51 | 0.54 |
EPS Growth | - | - | 31.05% | -39.41% | 178.91% | 135.49% |
Free Cash Flow | -454.45 | -47.47 | -1,064 | 380.51 | 242.16 | 136.25 |
Free Cash Flow Per Share | -1.44 | -0.15 | -3.54 | 1.34 | 0.93 | 0.61 |
Dividend Per Share | - | - | 0.137 | 0.277 | 0.405 | - |
Dividend Growth | - | - | -50.69% | -31.57% | - | - |
Gross Margin | 11.83% | 11.27% | 15.65% | 15.97% | 17.64% | 14.47% |
Operating Margin | -2.85% | -7.04% | 5.61% | 5.91% | 7.96% | 4.47% |
Profit Margin | -8.76% | -12.22% | 3.25% | 2.97% | 6.35% | 2.76% |
Free Cash Flow Margin | -4.00% | -0.41% | -9.60% | 4.35% | 3.89% | 3.09% |
EBITDA | -218.79 | -621.21 | 798.21 | 693.25 | 593.49 | 279.54 |
EBITDA Margin | -1.92% | -5.36% | 7.20% | 7.93% | 9.54% | 6.33% |
D&A For EBITDA | 105.83 | 193.77 | 176.75 | 176.36 | 98.19 | 82.27 |
EBIT | -324.62 | -814.99 | 621.46 | 516.89 | 495.3 | 197.27 |
EBIT Margin | -2.85% | -7.04% | 5.61% | 5.91% | 7.96% | 4.47% |
Effective Tax Rate | - | - | - | - | 3.35% | 35.77% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.